Showing results (1001-1010 of 9,116) with videos related to

Sort By:
Pageof 912
Cancer Medicine|September 8, 2022
Prognostic nomogram in patients with epithelioid sarcoma: A SEER-based studyDi Zhang, Jintao Hu, Zhuojie Liu, et al.
Cancer Medicine|October 6, 2022
Multimodal approach to the treatment of patients with radioiodine refractory differentiated thyroid cancer and metastases to the central nervous systemTeresa Alonso-Gordoa
Cancer Medicine|October 6, 2022
Clinical use of lenvatinib in patients with previous renal and/or hepatic impairment and radioiodine-refractory differentiated thyroid cancerJavier Martínez-Trufero
Cancer Medicine|October 6, 2022
Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancerUrbano Anido Herranz
Cancer Medicine|October 6, 2022
Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive-resistant differentiated thyroid cancerMarcel Sambo
Cancer Medicine|October 6, 2022
Use of multikinase inhibitors/lenvatinib concomitant with locoregional therapies for the treatment of radioiodine-refractory differentiated thyroid cancerMiguel-Ángel Berciano-Guerrero
Cancer Medicine|October 6, 2022
Inhibition of XPO1 impairs cholangiocarcinoma cell proliferation by triggering p53 intranuclear accumulationCheng Zhao, Ben Ma, Zi-Yi Yang, et al.
Cancer Medicine|October 8, 2022
Patient-reported disruptions to cancer care during the COVID-19 pandemic: A national cross-sectional studyJacob J Lang, Aparna Narendrula, Sharanya Iyer, et al.
Cancer Medicine|October 8, 2022
Patient-reported outcomes in childhood head and neck rhabdomyosarcoma survivors and their relation to physician-graded adverse events-A multicenter study using the FACE-Q Craniofacial moduleMichèle Morfouace, Marinka L F Hol, Reineke A Schoot, et al.
Cancer Medicine|October 8, 2022
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC"Sara Di Giusto, Eleonora Toffoletti, Massimiliano Bonifacio, et al.
Pageof 912